US 2023/0414410 A1Published application

Glaucoma treatment device

AssigneeAlcon Inc.

InventorsEugene DE JUAN, JR., Stephen BOYD, Mark E. DEEM, Hanson S. GIFFORD, III, Dan ROSENMAN

Life of this patent

Estimating the term…

Loading patent…

Abstract

Methods and devices are adapted for implanting into the eye. An incision is formed in the cornea of the eye and a shunt is inserted through the incision into the anterior chamber of the eye. The shunt includes a fluid passageway. The shunt is passed along a pathway from the anterior chamber through the scleral spur of the eye into the suprachoroidal space and positioned in a first position such that a first portion of the fluid passageway communicates with the anterior chamber and a second portion of the fluid passageway communicates with the suprachoroidal space to provide a fluid passageway between the suprachoroidal space and the anterior chamber.

Claims20

Dependent claims

An ocular implant system, comprising:

an ocular implant comprising an elongate core member,
wherein the elongate core member comprises an outer surface, and
wherein the elongate core member comprises a plurality of helical or spiral flow channels defined along the outer surface of the elongate core member;
and
a delivery instrument, comprising:
a hand-held component;
and
an elongated applier operatively coupled to the hand-held component wherein the elongated applier has an internal lumen and wherein the ocular implant is positioned inside the internal lumen, the elongated applier having a proximal region aligned with a longitudinal axis of the hand-held component and a distal region curved away from the longitudinal axis, wherein the delivery instrument is configured to:
pass the ocular implant across the anterior chamber past the scleral spur near the ciliary body of the eye towards the supraciliary space opposite the incision in the cornea;
and
position the ocular implant from inside the anterior chamber such that a proximal end of the ocular implant is in the anterior chamber and a distal end of the ocular implant is in fluid communication with the supraciliary space.

8 more elements

Dependencies are inferred from the claim text.

Facts

Application: 18/462,296Filed 6 Sep 2023
Priority: 17 Jan 2006
Published: 28 Dec 2023
Term ends: Not estimatedThe source records don’t support an estimate.

Classification22 codes

A61F 9/00781
Methods or devices for eye surgery: apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
A61B 34/70
Computer-aided surgery; Manipulators or robots specially adapted for use in surgery: manipulators specially adapted for use in surgery
A61B 90/00
Instruments, implements or accessories specially adapted for surgery or diagnosis and not
A61F 9/0008
Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind;…:…

Family

Application60/759,835Us provisional application · filed 17 Jan 2006
Application60/783,632Us provisional application · filed 17 Mar 2006
Application60/824,396Us provisional application · filed 1 Sep 2006
Application11/615,810Continuation · filed 22 Dec 2006
Application14/706,893Continuation · filed 7 May 2015
Application15/710,618Continuation · filed 20 Sep 2017
Application17/149,834Continuation · filed 15 Jan 2021
Application18/462,296Continuation
US 10,905,590 B2Related patent
US 11,786,402 B2Related patent
US 12,303,430 B2Related patent
US 2007/0191863 A1Published application
US 2015/0238360 A1Published application
US 2018/0092775 A1Published application
US 2021/0128357 A1Published application
US 8,721,656 B2Related patent
US 9,789,000 B2Related patent
US 2023/0414410 A1This patent

From the US filing history. Foreign family members aren’t listed.